Sign in

CIK 0001123494

  • Non-accelerated filer
  • Smaller reporting company

HARVARD BIOSCIENCE INC

Sign in to watch
Ticker
HBIO
Exchange
Nasdaq
Industry
Laboratory Analytical Instruments
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
043306140
Phone
+1 508-893-8999
Business address
84 OCTOBER HILL RD, HOLLISTON, MA, 01746
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2018-07-12 Gagnon Robert E. Chief Financial Officer Sale −9,145 $5.25 $48K 383,512
2018-07-12 Gagnon Robert E. Chief Financial Officer Exercise or conversion · Stock option (right to buy) −5,828 40,000
2018-07-11 Gagnon Robert E. Chief Financial Officer Exercise or conversion +62,100 $4.31 $268K 473,957
2018-07-11 Gagnon Robert E. Chief Financial Officer Exercise or conversion +54,172 $4.12 $223K 528,129
2018-07-11 Gagnon Robert E. Chief Financial Officer Sale −141,300 $5.23 $739K 386,829
2018-07-11 Gagnon Robert E. Chief Financial Officer Exercise or conversion · stock option (right to buy) −62,100 60,000
2018-07-11 Gagnon Robert E. Chief Financial Officer Exercise or conversion · Stock option (right to buy) −54,172 45,828
2018-07-11 Duchemin Jeffrey Chief Executive Officer Sale −14,205 $5.22 $74K 790,742
2018-07-10 Gagnon Robert E. Chief Financial Officer Exercise or conversion +13,700 $4.31 $59K 425,557
2018-07-10 Gagnon Robert E. Chief Financial Officer Sale −13,700 $5.38 $74K 411,857
2018-07-10 Gagnon Robert E. Chief Financial Officer Exercise or conversion · Stock option (right to buy) −13,700 122,100
2018-07-10 Duchemin Jeffrey Chief Executive Officer Sale −11,600 $5.38 $62K 804,947
2018-07-09 Gagnon Robert E. Chief Financial Officer Exercise or conversion +14,200 $4.31 $61K 426,057
2018-07-09 Gagnon Robert E. Chief Financial Officer Sale −14,200 $5.41 $77K 411,857
2018-07-09 Gagnon Robert E. Chief Financial Officer Exercise or conversion · Stock option (right to buy) −14,200 135,800
2018-07-09 Duchemin Jeffrey Chief Executive Officer Sale −14,195 $5.41 $77K 816,547
2018-06-01 KENNEDY JOHN F Director Grant or award +2,400 310,480
2018-06-01 Loewald Thomas W Director Grant or award +1,600 33,400
2018-06-01 Eade Katherine A. Director Grant or award +1,200 32,700
2018-05-24 Loewald Thomas W Director Grant or award +18,100 31,800

Page 16 of 17 · 324 trades